<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
49884-907-61
</NDCCode>
<PackageDescription>
480 mL in 1 BOTTLE, PLASTIC (49884-907-61)
</PackageDescription>
<NDC11Code>
49884-0907-61
</NDC11Code>
<ProductNDC>
49884-907
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Megestrol Acetate
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Megestrol Acetate
</NonProprietaryName>
<DosageFormName>
SUSPENSION
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20010725
</StartMarketingDate>
<EndMarketingDate>
20241231
</EndMarketingDate>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA075671
</ApplicationNumber>
<LabelerName>
Endo USA, Inc.
</LabelerName>
<SubstanceName>
MEGESTROL ACETATE
</SubstanceName>
<StrengthNumber>
40
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Progesterone Congeners [CS], Progestin [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2025-01-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20010725
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20241231
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>